News

Filter

Current filters:

Accurins

BIND Therapeutics in $50M deal with Pfizer, plus $160M per Accurins milestone

04-04-2013

US clinical stage, investor backed biopharma company BIND Therapeutics has entered into a global collaboration…

AccurinsBIND TherapeuticsBiotechnologyLicensingOncologyPfizerPharmaceuticalResearch

Back to top